[{"id":"a05c3ff4-1d35-42ee-99b9-d78d41b00e4b","acronym":"","url":"https://clinicaltrials.gov/study/NCT02835833","created_at":"2021-01-18T13:55:01.923Z","updated_at":"2024-07-02T16:37:09.067Z","phase":"Phase 1","brief_title":"Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors","source_id_and_acronym":"NCT02835833","lead_sponsor":"University of Alabama at Birmingham","biomarkers":" VEGFA • PIGF • FGF","pipe":"","alterations":" ","tags":["VEGFA • PIGF • FGF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • nintedanib"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 06/09/2016","start_date":" 06/09/2016","primary_txt":" Primary completion: 04/14/2018","primary_completion_date":" 04/14/2018","study_txt":" Completion: 06/14/2018","study_completion_date":" 06/14/2018","last_update_posted":"2018-07-10"}]